EyePoint Pharmaceuticals

EYPT62

$7.97arrow_drop_down1.11%-$0.09

EYPT62

$7.97

arrow_drop_down1.11%-$0.09

Performance History

Key Stats
Open	$8.06
Prev. Close	$8.06
EPS	-1.71
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	7.72	8.21
52 Week Range	5.67	30.99

Ratios







EPS	-1.71

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About EyePoint Pharmaceuticals (EYPT)

EyePoint Pharmaceuticals Inc (EYPT) is a pharmaceutical company that specializes in developing and commercializing innovative ophthalmic products. The company's mission is to improve the lives of patients with serious eye diseases through the delivery of effective and convenient treatment options. With a strong focus on research and development, EyePoint Pharmaceuticals is dedicated to advancing the field of ophthalmology and addressing the unmet needs of patients worldwide.

One of the key products in EyePoint Pharmaceuticals' portfolio is DEXYCU, which is the first and only FDA-approved intraocular steroid for the treatment of postoperative inflammation. DEXYCU offers a unique sustained-release formulation that provides consistent and prolonged delivery of dexamethasone, reducing the need for frequent injections. This not only improves patient compliance but also simplifies the treatment process for physicians.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Jay S. Duker M.D.
Headquarters: Watertown
Employees: 144
Exchange: NASDAQ

add EyePoint Pharmaceuticals to watchlist

Keep an eye on EyePoint Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is EyePoint Pharmaceuticals 's (EYPT) price per share?

The current price per share for EyePoint Pharmaceuticals (EYPT) is $7.97. The stock has seen a price change of -$0.09 recently, indicating a -1.12% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for EyePoint Pharmaceuticals (EYPT)?

For EyePoint Pharmaceuticals (EYPT), the 52-week high is $30.99, which is 288.83% from the current price. The 52-week low is $5.67, the current price is 40.56% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is EyePoint Pharmaceuticals (EYPT) a growth stock?

EyePoint Pharmaceuticals (EYPT) has shown an average price growth of 0.41% over the past three years. It has received a score of 89 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying EyePoint Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is EyePoint Pharmaceuticals (EYPT) stock price performance year to date (YTD)?

As of the latest data, EyePoint Pharmaceuticals (EYPT) has a year-to-date price change of -64.61%. Over the past month, the stock has experienced a price change of -11.64%. Over the last three months, the change has been -14.02%. Over the past six months, the figure is -69.04%. Looking at a longer horizon, the five-year price change stands at -47.57%.

help

Is EyePoint Pharmaceuticals (EYPT) a profitable company?

EyePoint Pharmaceuticals (EYPT) has a net income of -$70.8M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 89.93% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -364.52% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $46.02M, with a revenue growth rate of 11.14%, providing insight into the company's sales performance and growth. The gross profit is $41.39M. Operating income is noted at -$73.66M. Furthermore, the EBITDA is -$96.53M.

help

What is the market capitalization of EyePoint Pharmaceuticals (EYPT)?

EyePoint Pharmaceuticals (EYPT) has a market capitalization of $429.74M. The average daily trading volume is 395.41K, indicating the stock's liquidity and investor engagement.